香港创科发展：两年80间企业落户，投资超65亿美元

Core Insights - The biotechnology sector presents immense opportunities, with China emerging as the world's second-largest biopharmaceutical market and a leader in biotechnology [1] - Hong Kong is positioned as a gateway to the mainland market and a platform for mainland innovations to reach the global stage [1] Group 1: Hong Kong's Advantages - Hong Kong has multiple advantages that make it a reliable and trustworthy partner for technology development and investment collaboration [1] - The city is home to 4,700 startups and nearly 20 unicorn companies, many of which have been nurtured and supported by Science Park and Cyberport [1] Group 2: Recent Developments - Over the past two years, more than 80 technology companies have established operations in Hong Kong, with investments exceeding $6.5 billion and creating approximately 20,000 quality jobs [1]